Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. The Company's technology will broaden the end user experience through improved data quality and simplified workflows to benefit discoveries and diagnosis in healthcare.
At Element, we innovate through a combination of cutting-edge technologies and established solutions. Our practices govern through a passion and fervor for rigorous science, such that data and results drive timely decisions in ever evolving markets. We take risks to challenge the status quo. We celebrate success and thrive in failures. We commit to the highest quality products and foundational understanding of our technologies, and through that we disrupt the genomics industry and ultimately propel our understanding of biology to new levels.
Element Biosciences Secures $15 Million Series A Financing Led by Foresite Capital and Venrock
San Diego, CA, June 18 -- Element Biosciences, Inc., a company focused on the development of genetic analysis tools secures $15 million in Series A funding led by Foresite Capital and Venrock. Proceeds from the financing will support the development of disruptive technologies designed to significantly improve quality and reduce the cost of genomic applications.
"The capital raised will fuel the company's R&D to implement innovative changes across each element, from reagents to instrument to data analysis. We are on an aggressive path to introduce a high quality, flexible platform to make genetic analysis more accessible and adaptable to a broad customer base." said Molly He, co-founder and CEO of Element.
Element has assembled a preeminent leadership team with proven experience developing genetic tools. The Board of Directors comprises executives with broad experiences for each element of genetic analysis.
“During the last decade, we have seen genetic analysis become a mainstay of basic and clinical research primarily through platforms that resemble mainframe computers. As genetic analysis applications continue to explode, we expect the platforms to continue to evolve. We believe the Element team is well positioned to create new genetic analysis tools to meet maturing market needs,” says Jim Tananbaum, CEO and managing director of Foresite Capital.
“Materially improved pricing and performance benchmarks for genetic analysis, in an easy to use package, would dramatically increase use cases and thereby propel our understanding of biology to new levels. This is Element’s mission,” said Bryan Roberts, partner at Venrock.
We seek self-driven individuals that thrive in cross-functional teams. We seek risk-takers that are persistent and resilient. We seek those that garner satisfaction in overcoming challenges through hard work and technical or business acumen. Most importantly, we seek those that have a passion for learning. We are committed to providing opportunities to our colleagues so they can achieve the best versions of themselves in their career trajectories. Join our winning team!
We are enthusiastically looking for technical expertise in these areas: Fluidics Engineering, Electrical Engineering, Software Engineering, Biophysics, Bioconjugation, Protein Engineering, Assay Development, Human Resources, and Business Development.